Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Judit, Hársing"'
Autor:
András Bánvölgyi, Pinar Avci, Norbert Kiss, Fanni Adél Meznerics, Antal Jobbágy, Luca Fésűs, Judit Hársing, Enikő Kuroli, Ágota Szepesi, Márta Marschalkó
Publikováno v:
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 31, Iss , Pp 100370- (2023)
Tuberculosis remains a global health concern, as the increasing levels of urban poverty, higher number of immunodeficient patients and the development of drug resistance threaten the overall efforts made to induce a downward trend for the disease. Sc
Externí odkaz:
https://doaj.org/article/c3084bcc786d4de29c79e4c697cb9129
Autor:
Daniella Kuzmanovszki, Norbert Kiss, Béla Tóth, Tünde Kerner, Veronika Tóth, József Szakonyi, Kende Lőrincz, Judit Hársing, Eleonóra Imrédi, Alexa Pfund, Ákos Szabó, Valentin Brodszky, Fanni Rencz, Péter Holló
Publikováno v:
Biomedicines, Vol 10, Iss 7, p 1737 (2022)
Real-world evidence plays an important role in the assessment of efficacy and safety of novel therapies. The increasing use of immune checkpoint inhibitors (ICIs) in patients with advanced melanoma has led to notably improved clinical outcomes, while
Externí odkaz:
https://doaj.org/article/37bb6b0a7cac459e8647fdd6fed462d4
Frequent KIT mutations in skin lesions of patients with BRAF wild-type Langerhans cell histiocytosis
Autor:
Csaba Bödör, Béla E. Tóth, Judit Csomor, Sarolta Kárpáti, József Tímár, Norbert Kiss, Judit Hársing, Erzsébet Rásó
Publikováno v:
Virchows Archiv
Langerhans cell histiocytosis (LCH) is characterized by mutations of the RAS-RAF-MAPK signaling pathway. We analyzed MAP2K1, NRAS and KIT mutation incidence in skin lesions of BRAF wild-type (wt) LCH patients. We evaluated the occurrence of MAP2K1, N
Autor:
Enikő Kuroli, Dermatooncology, Melinda Fábián, Márta Medvecz, Krisztina Herszényi, Judit Hársing, Brigitte Diczig, Péter Holló, Bernadett Hidvégi, Sarolta Kárpáti, Miklós Sárdy
Publikováno v:
Bőrgyógyászati és Venerológiai Szemle. 95:117-121
Autor:
Judit Hársing, Norbert Kiss, Dóra Haluszka, Sarolta Kárpáti, György Fekete, Balázs Mayer, Dermatooncology, Róbert Szipőcs, Kende Lőrincz, Norbert Wikonkál, Márta Medvecz, Luca Fésűs, Szabolcs Bozsányi, Enikő Kuroli
Publikováno v:
Bőrgyógyászati és Venerológiai Szemle. 95:122-128
Autor:
Hagemeijer Yp, Huszty G, Attila Marcell Szász, Runyu Hong, Carneiro Gra, Elisabet Wieslander, de Almeida Np, Johan Malm, Bo Baldetorp, de Siqueira Guedes J, Jeovanis Gil, Laura Vízkeleti, Uğur Çakır, József Tímár, Judit Hársing, Roger Appelqvist, Magdalena Kuras, Beáta Szeitz, Lázaro Betancourt, Boram Lee, Henriett Oskolas, Melinda Rezeli, Aniel Sanchez, Yutaka Sugihara, Sarolta Kárpáti, Zsolt Horvath, Guryev, Johan Jakobsson, Yogita Sharma, György Marko-Varga, Doma, Jenny G Johansson, Yonghyo Kim, Indira Pla Parada, Gustavo Monnerat, Peter Horvatovich, Gilberto B. Domont, Enikő Kuroli, David Fenyö
SummaryMalignant melanoma (MM) develops from the melanocytes and in its advanced stage is the most aggressive type of skin cancer. Here we report a comprehensive analysis on a prospective cohort study, including non-tumor, primary and metastasis tiss
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::493b2312b5eca3caf67b93aff91681be
https://doi.org/10.1101/2021.04.10.439245
https://doi.org/10.1101/2021.04.10.439245
Autor:
Anita Varga, Judit Hársing, Péter Holló, Daniella Kuzmanovszki, Norbert Wikonkál, Béla E. Tóth, József Szakonyi
Publikováno v:
Bőrgyógyászati és Venerológiai Szemle. 93:155-159
Autor:
Krisztián Németh, Fanni Rencz, Sarolta Kárpáti, Petra Balogh, Valentin Brodszky, Judit Hársing, Melinda Fábián, Tibor Krenács
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 31:1453-1461
Background The hormone sensitivity of melanoma and the role of ‘classical’ estrogen receptor (ER) α and β in tumor progression have been intensively studied with rather contradictory results. The presence of ‘non-classical’ G protein-couple
Autor:
Norbert Kiss, Zsófia Hatvani, Márta Medvecz, Mercédesz Mazán, Sarolta Kárpáti, Norbert Wikonkál, Kende Lőrincz, Judit Hársing, R. Lepesi-Benkő, Annamária Glász-Bóna
Publikováno v:
Clinical and Experimental Dermatology. 43:972-974
Autor:
Judit Hársing, Kárpáti Sarolta, Ágota Szepesi, Zsuzsánna Károlyi, András Matolcsy, Enikő Kuroli, Judit Csomor, Márta Marschalkó, Nóra Gyöngyösi, Judit Noll, Norbert Wikonkál
Publikováno v:
Journal of Cutaneous Pathology. 43:963-973
Lymphomatoid papulosis (LyP) belongs to CD30+ lymphoproliferative disorders with indolent clinical course. Classic histological subtypes, A, B and C are characterized by the CD4+ phenotype, while CD8+ variants, most commonly classified as type D, wer